Details for New Drug Application (NDA): 203554
✉ Email this page to a colleague
NDA 203554 describes PENTOSTATIN, which is a drug marketed by Rising and West-ward Pharms Int and is included in two NDAs. Additional details are available on the PENTOSTATIN profile page.
The generic ingredient in PENTOSTATIN is pentostatin. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pentostatin profile page.
The generic ingredient in PENTOSTATIN is pentostatin. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pentostatin profile page.
Summary for 203554
| Tradename: | PENTOSTATIN |
| Applicant: | Rising |
| Ingredient: | pentostatin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 203554
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/VIAL | ||||
| Approval Date: | Sep 19, 2014 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
